Evaluation of urinary prostaglandin E2 metabolite as a biomarker in infants with fever due to viral infection.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Prostaglandins, Leukotrienes and Essential Fatty Acids

• Publication date

  2014-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.plefa.2014.09.006PMID 25305792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.

  2014cited by this paper
• Prostaglandin E–Major Urinary Metabolite as a Reliable Surrogate Marker for Mucosal Inflammation in Ulcerative Colitis

  2014cited by this paper
• Prostaglandin E2: the villain in the host response to influenza virus.

  2014cited by this paper
• The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

  2013cited by this paper
• Glomerular function in neonates.

  2012cited by this paper
• Assessment of oxidative stress markers and prostaglandins after chronic training of triathletes.

  2012cited by this paper
• Fever and Antipyretic Use in Children

  2011cited by this paper
• Effects of celecoxib on major prostaglandins in asthma

  2011cited by this paper
• An inflammatory pathway to apnea and autonomic dysregulation.

  2011cited by this paper
• Simultaneous and high-throughput quantitation of urinary tetranor PGDM and tetranor PGEM by online SPE-LC-MS/MS as inflammatory biomarkers.

  2011cited by this paper
• Chronic prostaglandin E2 treatment induces the synthesis of the pain‐related peptide substance P and calcitonin gene‐related peptide in cultured sensory ganglion explants

  2010cited by this paper
• Quantification of urinary PGEm, 6-keto PGF(1alpha) and 2,3-dinor-6-keto PGF(1alpha) by UFLC-MS/MS before and after exercise.

  2010cited by this paper
• Characterization and pharmacological evaluation of febrile response on zymosan-induced arthritis in rats.

  2009cited by this paper
• Levels of Prostaglandin E Metabolite and Leukotriene E4 Are Increased in the Urine of Smokers: Evidence that Celecoxib Shunts Arachidonic Acid into the 5-Lipoxygenase Pathway

  2009cited by this paper
• Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?

  2009cited by this paper
• Mechanistic basis of using body size and maturation to predict clearance in humans.

  2009cited by this paper
• Tetranor PGDM, an Abundant Urinary Metabolite Reflects Biosynthesis of Prostaglandin D2 in Mice and Humans*

  2008cited by this paper
• Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man

  2008cited by this paper
• Cardiorespiratory development in extremely preterm infants: vulnerability to infection and persistence of events beyond term‐equivalent age

  2008cited by this paper
• Liquid chromatography-tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E(2) in human urine.

  2008cited by this paper
• The induced prostaglandin E2 pathway is a key regulator of the respiratory response to infection and hypoxia in neonates

  2007cited by this paper
• Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target

  2007cited by this paper
• Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method.

  2007cited by this paper
• A short review of some of the highlights in the history of an almost quinquagenarian

  2005cited by this paper
• Impaired febrile responses to immune challenge in mice deficient in microsomal prostaglandin E synthase-1.

  2005cited by this paper
• Interleukin-1beta depresses hypoxic gasping and autoresuscitation in neonatal DBA/1lacJ mice.

  2005cited by this paper
• Interferon: ten stories in one. A short review of some of the highlights in the history of an almost quinquagenarian.

  2005cited by this paper
• C-reactive protein: ligands, receptors and role in inflammation.

  2005cited by this paper
• Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E2, Are Increased in Smokers

  2005cited by this paper
• Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.

  2004cited by this paper
• Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis

  2003cited by this paper
• Prostaglandin catabolizing enzymes.

  2002cited by this paper
• Renal aspects of the term and preterm infant: a selective update.

  2002cited by this paper
• Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord.

  2001cited by this paper
• Prostaglandins and cycloxygenases in the spinal cord

  2001cited by this paper
• Erratum to “Prostaglandins and cyclooxygenases in the spinal cord” [Progress in Neurobiology 64 (2001) 327–363]

  2001cited by this paper
• Neonatal urinary prostanoid excretion.

  2000cited by this paper
• PGE2 modulates the tetrodotoxin‐resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP‐protein kinase A cascade.

  1996cited by this paper
• Normalization of glomerular filtration rate in children: body surface area, body weight or extracellular fluid volume?

  1994cited by this paper
• Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children

  1992cited by this paper
• Weight as the best standard for glomerular filtration in the newborn.

  1984cited by this paper
• A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.

  1982cited by this paper
• Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies.

  1976cited by this paper
• Prostaglandins.

  1975cited by this paper
• Viral Infection and Host Defense

  1974cited by this paper
• Inhibition of prostaglandin synthesis in man.

  1972cited by this paper
• Human placental 15-hydroxyprostaglandin dehydrogenase.

  1972cited by this paper
• Prostaglandins, aspirin-like drugs and analgesia.

  1972cited by this paper
• On the metabolism of prostaglandins E 1 and E 2 in man.

  1971cited by this paper
• On the Metabolism of Prostaglandins E1 and E2 in Man

  1971cited by this paper
• The Biological Activities of Three Metabolites of Prostaglandin E1

  1966cited by this paper
• The biological activities of three metabolites of prostaglandin E 1.

  1966cited by this paper
• PROSTAGLANDINS AND RELATED FACTORS. 28. METABOLISM OF PROSTAGLANDIN E1 IN GUINEA PIG LUNG: THE STRUCTURES OF TWO METABOLITES.

  1964cited by this paper

• Evaluation of a Chemiluminescent Enzyme Immunoassay for the Detection of Prostaglandin E‐Major Urinary Metabolite (PGE‐MUM)

  2024cites this paper
• Microsomal prostaglandin E synthase‐1 inhibition prevents adverse cardiac remodelling after myocardial infarction in mice

  2023cites this paper
• A single extraction 96-well method for LC-MS/MS quantification of urinary eicosanoids, steroids and drugs.

  2023cites this paper
• Targeted Lipidomics for Characterization of PUFAs and Eicosanoids in Extracellular Vesicles

  2022cites this paper
• Prostanoid Metabolites as Biomarkers in Human Disease

  2022cites this paper
• Lipid mediators in marine diatoms

  2022cites this paper
• Urinary 8-iso PGF2α and 2,3-dinor-8-iso PGF2α can be indexes of colitis-associated colorectal cancer in mice

  2021cites this paper
• Vital signs as physiomarkers of neonatal sepsis

  2021cites this paper
• Simultaneous Quantitation of Lipid Biomarkers for Inflammatory Bowel Disease Using LC–MS/MS

  2021cites this paper
• Variation in prostaglandin metabolism during growth of the diatom Thalassiosira rotula

  2020cites this paper
• Bronchoprovocation studies to define mechanisms in asthma and airway inflammation

  2019cites this paper
• Astrocyte networks modulate respiration - sniffing glue.

  2019cites this paper
• Prostaglandin E-major urinary metabolite as a noninvasive surrogate marker for infantile necrotizing enterocolitis.

  2019cites this paper
• Urinary PGE2 metabolite levels in hospitalised infants with infections compared to age‐matched controls

  2019cites this paper
• Urinary prostaglandin D2 and E2 metabolites associate with abdominal obesity, glucose metabolism, and triglycerides in obese subjects.

  2019cites this paper
• Vitamin B12 Status Upon Short-Term Intervention with a Vegan Diet—A Randomized Controlled Trial in Healthy Participants

  2019cites this paper
• Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor

  2018cites this paper
• Simultaneous Quantitation of Isoprenoid Pyrophosphates in Plasma and Cancer Cells Using LC-MS/MS

  2018cites this paper
• Quantification of eicosanoids and their metabolites in biological matrices: a review.

  2018cites this paper
• Urinary prostaglandin D2 metabolite excretion during the first six months of life was significantly lower in breast‐fed than formula‐fed infants

  2018cites this paper
• Simultaneous LC-MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF.

  2018cites this paper
• Children as Biomarker Orphans: Progress in the Field of Pediatric Biomarkers.

  2017cites this paper
• The breathing brainstem : development of inspiration

  2017cites this paper
• Prostaglandin D2 metabolite in urine is an index of food allergy

  2017cites this paper
• The relevance of immune responses to partial bladder outlet obstruction and reversal

  2016cites this paper
• Prostaglandin E2 Mediates Cardiorespiratory Disturbances during Infection in Neonates.

  2015cites this paper
• Roles of lipid-modulating enzymes diacylglycerol kinase and cyclooxygenase under pathophysiological conditions

  2014cites this paper